MTHFR and HFE, but Not Preproghrelin and LBP, Polymorphisms as Risk Factors for All-Cause End-Stage Renal Disease Development Cited by

Folia Biologica > Archive > 2014, Vol. 60 > Issue 2 > p. 83 > Cited by

Fol. Biol. 2014, 60, 83-88

https://doi.org/10.14712/fb2014060020083

Silvie Bloudíčková, L. Kuthanová, J. A. Hubáček

Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

Received November 2013
Accepted December 2013

Hubacek J.A., Philipp T., Adamkova V., Majek O., Dusek L.: A haemochromatosis-causing HFE mutation is associated with SARS-CoV-2 susceptibility in the Czech population. Clinica Chimica Acta 2023, 538, 211. <https://doi.org/10.1016/j.cca.2022.12.025>
Chang Hsueh-Lu, Chen Guei-Rung, Hsiao Po-Jen, Chiu Chih-Chien, Tai Ming-Cheng, Kao Chung-Cheng, Tsai Dung-Jang, Su Hao, Chen Yu-Hsuan, Chen Wei-Teing, Su Sui-Lung: Decisive evidence corroborates a null relationship between MTHFR C677T and chronic kidney disease. Medicine 2020, 99, e21045. <https://doi.org/10.1097/MD.0000000000021045>
Ostrakhovitch E.A., Tabibzadeh S.: Homocysteine and age-associated disorders. Ageing Research Reviews 2019, 49, 144. <https://doi.org/10.1016/j.arr.2018.10.010>